Find your next paid study

University of MiamiNCT07502352

Advanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid Tumor+3 more

First-in-Human Phase I Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Background: Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths. No treatment specifically prevents or re…

National Cancer Institute (NCI)NCT04222413

~$10 – $5,625

Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+1 more

A Phase 1 Study in Patients With Clinically Node-Positive Breast Cancer to Assess the Safety, Ultrasound Conspicuity, and Migration of an Optimized Ultrasound Twinkling Marker Observed for Sonographic Targeting (UTMOST2 Trial)

This phase I trial studies the performance, including ultrasound visibility, of an optimized ultrasound twinkling marker in imaging lymph nodes in patients wit…

Breast CancerLocally Advanced Breast CancerMetastatic Breast Cancer+2 more

Mayo ClinicNCT06999798

Phase 3

A Phase 3 Randomized, Double-Blind, Active-Controlled Study of Palazestrant With Ribociclib Versus Letrozole With Ribociclib for the First-Line Treatment of ER+, HER2- Advanced Breast Cancer (OPERA-02)

This phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received…

Olema Pharmaceuticals, Inc.NCT07085767

~$10 – $8,750

Hormone Receptor Positive Early Breast Cancer

An Open-Label, One-Sequence Study to Evaluate the Steady-State Comparative Bioavailability of Quarterly Letrozole SIE and Once Daily 2.5 mg Oral Letrozole (Femara®) in Post-Menopausal Women Treated With Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer. (SIE-1)

The study aims to compare the amount of the drug letrozole that gets into the bloodstream after multiple doses of the quarterly injection Letrozole SIE, versus…

Rovi Pharmaceuticals LaboratoriesNCT07401381

~$10 – $8,750

Observational

Precise Oncology Interventions in Nutrition and Training (OnPoint)

The purpose of this study is to see if survivors of breast, prostate, colorectal or lymphoma cancer who receive a personal referral to a targeted nutrition and…

Breast CancerProstate CancerColorectal Cancer+1 more

University of MiamiNCT06534918

Intra-Operative Radiation Therapy (IORT) Using the IntraBeam® System - A Registry Protocol

This registry trial is designed to track the local control rates and side effects of IORT, which will be implemented for women who are suitable partial breast …

Breast Cancer

Albert Einstein College of MedicineNCT04994067

~$10 – $750

Observational

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab - Phase 2

The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast …

Breast CancerAnthracycline Related Cardiotoxicity in Breast CancerVirtual Reality+1 more

Virginia Commonwealth UniversityNCT07426913

Observational

A Pilot Trial of a Community-Based Strategy to Improve Colorectal and Breast Cancer Screening

The goal of the proposed study is to conduct a pilot randomized controlled trial (RCT) of Chi gung, a community-based intervention using peer education and tai…

Colorectal NeoplasmsBreast Neoplasms

Icahn School of Medicine at Mount SinaiNCT07748377

Phase 2

preEMBER: A Phase 2, Open-label Study Evaluating Imlunestrant in Premenopausal Women With Estrogen Receptor-Positive, HER2-Negative Breast Cancer

This study will include two groups of patients: Cohort 1 and Cohort 2. Cohort 1: will help researchers learn how a medicine called imlunestrant (LY3484356) af…

Breast Neoplasms

Eli Lilly and CompanyNCT07287098

~$10 – $7,500

Phase 2

Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

The researchers are doing this study to compare two different types of group therapy and find out whether they are effective approaches for helping breast canc…

Breast Cancer Survivor

Memorial Sloan Kettering Cancer CenterNCT06728579

Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more

A Phase 1a/b Multicenter, Open-Label Trial to Evaluate Safety, Tolerability, and Dosimetry of LY4257496, a GRPR-Targeted Radioligand Therapy, in Adults With GRPR-Positive Advanced Solid Tumors (OMNIRAY)

The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relevant standard of care (SOC) combination …